| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |